Source:http://linkedlifedata.com/resource/pubmed/id/17378544
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2007-4-12
|
pubmed:abstractText |
2, N6, and 5'-substituted adenosine derivatives were synthesized via alkylation of 2-oxypurine nucleosides leading to 2-arylalkylether derivatives. 2-(3-(Indolyl)ethyloxy)adenosine 17 was examined in both binding and cAMP assays and found to be a potent agonist of the human A2BAR. Simplification, altered connectivity, and mimicking of the indole ring of 17 failed to maintain A2BAR potency. Introduction of N6-ethyl or N6-guanidino substitution, shown to favor A2BAR potency, failed to enhance potency in the 2-(3-(indolyl)ethyloxy)adenosine series. Indole 5' '- or 6' '-halo substitution was favored at the A2BAR, but a 5'-N-ethylcarboxyamide did not further enhance potency. 2-(3' '-(6' '-Bromoindolyl)ethyloxy)adenosine 28 displayed an A2BAR EC50 value of 128 nM, that is, more potent than the parent 17 (299 nM) and similar to 5'-N-ethylcarboxamidoadenosine (140 nM). Compound 28 was a full agonist at A2B and A2AARs and a low efficacy partial agonist at A1 and A3ARs. Thus, we have identified and optimized 2-(2-arylethyl)oxo moieties in AR agonists that enhance A2BAR potency and selectivity.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0022-2623
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
19
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1810-27
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:17378544-Adenosine,
pubmed-meshheading:17378544-Adenosine A2 Receptor Agonists,
pubmed-meshheading:17378544-Animals,
pubmed-meshheading:17378544-Binding, Competitive,
pubmed-meshheading:17378544-Binding Sites,
pubmed-meshheading:17378544-CHO Cells,
pubmed-meshheading:17378544-Cricetinae,
pubmed-meshheading:17378544-Cricetulus,
pubmed-meshheading:17378544-Cyclic AMP,
pubmed-meshheading:17378544-Humans,
pubmed-meshheading:17378544-Models, Molecular,
pubmed-meshheading:17378544-Stereoisomerism,
pubmed-meshheading:17378544-Structure-Activity Relationship
|
pubmed:year |
2007
|
pubmed:articleTitle |
Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.
|
pubmed:affiliation |
Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-0810, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Intramural
|